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 Intraocular surgery commonly results in postoperative
intraocular inflammation. This is thought to result from trauma
to ocular structures, disruption of the blood barrier, an im-
mune hypersensitivity reaction, or an infective-immune re-
sponse. This inflammatory response plays an important role
in the outcome of a variety of surgical procedures, for ex-
ample, it may be associated with a reduction in survival of a
transplanted cornea [1], predisposition to cystoid macular
edema [2], or a failure of glaucoma filtration surgery [3]. Con-
trol of the inflammatory response is, therefore, likely to be
important in determining the success of surgery. Character-
ization of aqueous cytokines may be helpful in staging dis-
ease activity and in correlating cytokine profiles with clinical
signs [4-8]. The cytokine response may be important in en-
dothelial loss following intraocular surgery. For example,
whereas IL-8 and IL-10 have roles in suppressing inflamma-
tion and aid vascular endothelial cell survival [9,10], TNF,
IL-6, and IFN-γ are linked with vascular endothelial cell
apoptosis [11,12]. Although there have been few studies on
the cytokine response to intraocular surgery, IL-6 is likely to
be a key mediator of postoperative uveitis and has been shown
in both animal [13] and human [14] studies to significantly
increase following intraocular surgery.
Cardiopulmonary bypass (CPB) has been proposed as a
model for systemic inflammatory response syndrome [15,16].
The anesthetic agent, ketamine, has been found to attenuate
the IL-6 response after cardiopulmonary bypass (CPB) [17].
Thus far, it is not known if the systemic anti-inflammatory
effect of ketamine extends to the eye to cause suppression of
post-ocular surgery inflammation. Although systemic (plasma)
concentrations of IL-1β, TNF-α, and IL-8 have been found to
increase following both general and local anesthesia for cata-
ract surgery [18], these, as well as other aqueous cytokines,
have not been measured in the aqueous humor following in-
traocular surgery. Therefore, we sought to characterize the
cytokine response to intraocular surgery using cataract sur-
gery as the model and to determine whether ketamine had a
similar effect found with systemic inflammation.
METHODS
Patients:  Patients undergoing routine uncomplicated cataract
surgery either under general or local (peribulbar) anesthesia
were enrolled into the study after obtaining their informed
consent. The decision whether surgery was to be carried out
under general or local anesthesia had been determined inde-
pendently by the patient’s ophthalmologist and was unrelated
to potential inclusion in this study. The study protocol was
approved by the local Research Ethics Committee and the
Declaration of Helsinki was adhered to. Patients were excluded
if they were using or had used immunosuppressive medica-
tion, were using topical ophthalmic medication, had a history
of autoimmune disease or other systemic inflammatory dis-
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Methods: Patients undergoing routine cataract surgery under general and local (peribulbar) anesthesia were randomized
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(p=0.038). There were no significant differences in aqueous cytokine levels following the use of ketamine or between
those patients who had general and local anesthesia (0.11<p<0.97).
Conclusions: There is an aqueous and serum cytokine response following intraocular surgery whether local (peribulbar)
or general anesthesia is used. Of the aqueous cytokines measured, three different patterns of responses emerged at 18 h
post-cataract surgery; those that were highly increased (IL-8, IL-6, IFN-γ, and TNF-α), medium increase (IL-1β, VEGF,
IL-4, and MCP-1), and those with little to no change (EGF, IL-1α, IL-2, and IL-10).
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1130ease within the past 5 years, or had a known hypersensitivity
to ketamine. Patients were not excluded if they had controlled,
non-insulin dependent diabetes mellitus and had not had or
required retinal laser treatment. Patients were randomly se-
lected from three groups: those undergoing cataract surgery
under general anesthesia with ketamine (GA+ or group 1),
those without ketamine (GA- or group 2), and those having
local (peribulbar) anesthesia without ketamine (LA or group
3).
Surgical procedure:  Standard small incision (3.2 mm)
cataract surgery using phacoemulsification was performed by
four experienced cataract surgeons. Preoperative assessment
of cataract density was made by a single surgeon using the
LOCSIII grading system [19]. The length of the procedure,
phacoemulsification time and power, and untoward events
during the procedure such as iris touch or hemorrhage were
recorded. All patients received the same preoperative topical
medication, namely guttae cyclopentolate 1% and phenyle-
phrine 2.5%. A subconjunctival injection of gentamicin 5 mg
was given at the end of the procedure. Towards the end of the
study, patients received intracameral vancomycin (1 mg in 0.1
ml) in line with changed departmental antimicrobial prophy-
laxis protocol for cataract surgery. Postoperative topical medi-
cation was a reducing regime of guttae betamethasone 0.4%
and chloramphenicol 0.5%. Postoperative treatment was not
commenced until the 18 h sample had been collected.
Anesthetic procedure:  All patients had cataract surgery
on a Thursday afternoon theatre list (2-5 p.m.). General anes-
thesia was induced intravenously with a bolus dose of propofol
1-2 mg/Kg and was maintained using volatile vapor of
isoflurane 1% in an oxygen and nitrous oxide mixture. Fenta-
nyl (1 µg/Kg) provided analgesia and atracurium (0.5 mg/Kg)
was used to provide neuromuscular blockade and to facilitate
ventilation and oxygenation. Ketamine (1 mg/Kg) was admin-
istered by an I.V. infusion over the duration of the surgery.
Postoperatively, cocodamol was administered orally every six
h, as required, to alleviate pain. Local anesthesia was admin-
istered by a peribulbar injection of 5 ml of a mixture of Li-
gnocaine 2% and Levobupivacaine 0.5%.
Sample Collection:  Aqueous and serum samples were
collected on the first postoperative morning (9-11 a.m.), ap-
proximately 18 h from the time of their cataract surgery. Five
milliliters of venous blood and 100 µl of aqueous (obtained
through the cataract side port incision) were obtained at the
commencement of surgery and prior to the administration of
ketamine. The side port incision was placed anterior to the
limbus to avoid any bleeding. The postoperative samples (aque-
ous and venous blood) were collected at 18 h postoperatively.
The postoperative aqueous sample was collected as follows.
Following topical anesthesia with guttae proxymethocaine, the
side port site was dabbed with a cotton bud dipped in a 5%
betadine solution. Using slit lamp biomicroscopy, a Pierce
hydrodissection cannula attached to a 1 ml tuberculin syringe
was inserted by one operator into the side port incision flush
with the internal opening into the anterior chamber. Then, the
second operator withdrew 30-50 µl of aqueous humor; the
amount of aqueous withdrawn was determined by monitoring
the depth of the anterior chamber. All samples were stored at -
80 °C for subsequent analysis.
Clinical outcome measures:  Intraocular inflammation was
assessed preoperatively and at 18 h by grading the anterior
chamber flare (F) from one to four and counting the number
of cells (C) in a 0.2 mm beam under 25X magnification. Com-
plications during sampling, postoperative complications, and
visual acuity of patients were recorded.
Analysis of samples:  Levels of interleukins (IL) -1α, IL-
1β, IL-2, IL-4, IL-6, IL-8, IL-10, vascular endothelial growth
factor (VEGF), tumor necrosis factor-α (TNF-α), interferon-
γ(IFN-γ), epidermal growth factor (EGF), and monocyte
chemotactic protein-1 (MCP-1) were measured using a Biochip
Array System [20] (Evidence Investigator, Randox Ltd, Co.
Antrim, N. Ireland). The biochip is a solid substrate with mul-
tiple specific cytokine antibodies attached at predefined sites
on the surface. Each cytokine binds to its specific antibody
then appropriate enzyme-labeled second antibodies are added
and the cytokines are quantified by chemiluminescence using
a CCD camera and imaging system. Samples were thawed
immediately before analysis, diluted 1:3 if necessary to en-
sure a volume greater than 100 µl, and 100 µl of the samples
were applied directly to each reaction well in the Biochip.
Samples were analyzed in two batches where all samples from
the same patient were analyzed in the same batch. The be-
tween-batch variability for all analytes was less than 12% and
within-batch variability less than 10%. As there is little infor-
mation available on the aqueous concentration of some of the
cytokines, it was not possible to determine the most appropri-
ate dilution for sample analysis.
Statistical Analysis:  For some of the cytokines, it was
not possible to determine the lower or upper values due to
lack of sufficient sample for further dilution or concentration.
Therefore, the concentrations were ranked, a Friedman test
for related samples was used to compare the three groups, and
a Kolmogorov-Smirnov test to compare pre to postoperative
levels using SPSS (version 14.1) statistical program. A cor-
rection factor for multiple testing was made to alpha where
indicated.
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TABLE 1 (NEXT PAGE). PRE AND POSTOPERATIVE AQUEOUS CYTOKINE RESPONSE FOLLOWING CATARACT SURGERY
Patient groups: general anesthesia with (GA+) and without (GA-) ketamine, and local anesthesia (LA). Cataract classification: nuclear opal-
escence (NO) and nuclear color (NC), and cortical (C) and posterior subcapsular (P) lens opacities. Anterior chamber inflammation: aqueous
flare (F), scale 1-4; cells (C) in the anterior chamber, that is, number of cells in a 0.2 mm beam graded as 0 (no cells), 1 (1-3 cells) and 2 (3-5
cells). Effective phacoemulsification time (EPT) is the product of average power and time. Aqueous cytokines: interleukin (IL)-1α, IL-1β, IL-
4, IL-6, IL-8, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNFα), interferon (IFN)-γ, epidermal growth factor
(EGF), and monocyte chemotactic protein-1 (MCP-1). Note the comparative changes in the pre and postoperative levels of the measured
aqueous cytokines such as IL-6 and IL-2. Also compare with Table 3 for serum responses of these cytokines. There were no differences
between the three patient groups and no correlation with grade of cataract or EPT.
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TABLE 1 (LEGEND PREVIOUS PAGE).
1132RESULTS
 Fifty-two patients were enrolled into the study. Fifteen pa-
tients withdrew from the study prior to taking of second sample
and were excluded. Eleven patients (mean age 69 years,
female:male=7:4), 11 patients (mean age 74 years,
female:male=9:2) and 15 patients (mean age 75 years,
female:male=9:6) were categorized into groups 1, 2, and 3,
respectively, giving 37 sets of samples (Table 1).
Clinical outcome:  The effective phacoemulsification time
(EPT), derived from multiplying average phacoemulsification
power and the phacoemulsification time, and the grade of cata-
ract for each patient is included in Table 2 along with the de-
gree of postoperative inflammation. No patient developed any
unexpected preoperative complication. Postoperatively, 29 and
8 patients had grade 1 and 2 flare, respectively. Twenty-two,
fourteen, and one patients had anterior chamber cell counts of
grade 1, 2, and 3, respectively (Table 1). There was no signifi-
cant difference between the EPT for the three groups, which
were 0.75, 0.60, and 0.60 for groups 1, 2, and 3, respectively
(p=0.57).
Complications of sampling:  One patient each from groups
1 and 2 complained of discomfort and headache following
collection of the postoperative aqueous sample at 18 h. In group
3 (LA), one patient’s anterior chamber shallowed to approxi-
mately 1.5 to 2 mm during the postoperative sampling proce-
dure but reformed satisfactorily after padding of the eye for
ten min. All three patients had good visual acuities postopera-
tively (6/6, 6/5, and 6/9, respectively) with an uneventful clini-
cal course.
Aqueous cytokines:  The pre and postoperative aqueous
cytokine concentrations are included in Table 1.
Preoperative levels:  Apart from IL-1β and EGF, there
were detectable levels of the remaining cytokines in the aque-
ous humor. In particular, all patients had relatively high aque-
ous levels of MCP-1 and VEGF compared to the remaining
other cytokines analyzed. In ten patients (patients 2, 6-8, 12,
22, 30, 33, 34, and 37) aqueous but not serum levels of IL-6
were relatively raised preoperatively (Table 1). Of these ten
patients, two had atrophic macular degeneration (one other
patient with dry age-related macular degeneration did not have
raised aqueous IL-6), two had non-insulin dependent diabetes
mellitus, one had had removal of a pterygium three years prior
to cataract surgery and one had had a trabeculectomy six years
prior to cataract surgery.
Postoperative aqueous cytokine concentrations:  Some
of the cytokine measurements showed little to no increase while
others showed many fold increases. There were significant
differences between all of the pre and postoperative aqueous
cytokine levels (0.003<p<0.001) except perhaps for IL-2
(p=0.07) and IL10 (p=0.05) especially if alpha is adjusted to
0.005. There were, however, no differences in the pre to post-
operative cytokine levels between the three patient groups,
GA+, GA-, and LA, for all of the 12 cytokines measured
(0.069<p<0.886). Additionally, there was no difference in the
change in aqueous cytokines between patients who had gen-
eral and local anesthesia (0.11<p<0.97). The pre to postop-
erative changes in concentration could be approximately
grouped into three semi-quantitative classes: those showing
little to no increase, EGF, IL-1α, IL-2, and IL-10; medium
increase, IL-1β, VEGF, IL-4, and MCP-1; and those showing
a high (many fold) increase, IL-8, IL-6, IFN-γ, and TNF-α.
This is reflected in Figure 1 as the ratio of the post to preop-
erative aqueous cytokine levels (used for descriptive purposes,
the lower and upper limit of detection as appropriate and in-
cluded in Table 2 as the mean pre and postoperative aqueous
cytokine levels). There was no apparent correlation between
the EPT and the ratio of post to preoperative aqueous cytokine
ratios (0.06<p<0.87).
Serum cytokine levels:  The preoperative and postopera-
tive serum levels for the cytokines measured are shown in
Figure 2 (ratio of the post to preoperative serum cytokine lev-
els) and included in Table 3. There were small but significant
increases in IFN-γ (p=0.005), IL-6 (p=0.02), IL-8 (p=0.03),
VEGF (p=0.003), and TNF-α (p=0.013). Although, if alpha is
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TABLE 2. MEAN PRE AND POSTOPERATIVE AQUEOUS CYTOKINE LEVES
Patient groups: general anesthesia with (GA+) and without (GA-) ketamine, and local anesthesia (LA). Aqueous cytokines: interleukin (IL)-
1α, IL-1β, IL-4, IL-6, IL-8, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNFα), interferon (IFN)-γ, epidermal
growth factor (EGF), and monocyte chemotactic protein-1 (MCP-1). It should be noted that to determine the approximate mean values, a cut-
off value at either the lower or higher concentration range was used. The values in this table should, therefore, only be considered as an
approximated concentration. Although there were large differences in the mean pre to postoperative aqueous cytokine responses there were no
significant differences between the three patient groups.
1133adjusted to 0.005 to correct for multiple testing (ten cytokines),
these effects can only be considered preliminary. For the aque-
ous concentrations, there were no significant differences in
the pre and postoperative serum levels between the three groups
(0.20<p<0.96). Three patients (two GA-, one GA+) had rela-
tively raised preoperative serum but not aqueous IL-6 levels.
No systemic reasons for the raised preoperative serum IL-6
levels were identified.
DISCUSSION
 Methodologies for studying the cellular infiltration and the
presence of various cytokines in aqueous humor range from
conventional assay methods like ELISA (and sequential
ELISA) to techniques such as flow cytometric multiplex ar-
ray (CBA) [21,22] and multiple bead immunoassay [8]. More
recently, biochips using protein array technology have made
possible, simultaneously, detection of multiple analytes, re-
duction in sample and reagent volumes, and high output of
test results. Intra- and inter-assay imprecision for most of the
analytes in this study was <10% and comparison studies have
shown compatible results with other methods for measure-
ment of cytokines [20]. Because the samples were batch tested
and there was a limited amount of sample (40 µl), it was not
possible to determine the optimum dilution for each cytokine.
This resulted in the difficulty in determining the precise con-
centration for some cytokines, hence, there was a cut-off, for
example, at either less than 0.1 or greater than 350 pg/ml.
Nevertheless the post to preoperative changes were often many
fold greater. Although every attempt was made to immedi-
ately store the samples, it is possible that there was degrada-
tion of the cytokines prior to storage and as the sample warmed,
its concentration was altered. The ratio of post to preoperative
concentrations should, however, be reflective of the surgical
effect. Although it would have been useful to measure total
protein concentration, all of the aqueous samples were used
up to meet the volume requirements for the Biochip assays.
While it is likely that there may have been a change in aque-
ous protein concentration from preoperative to postoperative,
the changes in cytokines were so great that the pre to postop-
erative results remain valid. Similarly, the cytokine concen-
trations relative to each would be the same.
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Figure 1. Ratio of post (18 h) to preop-
erative aqueous cytokine levels follow-
ing cataract surgery.  The post to preop-
erative aqueous cytokine ratio was deter-
mined using the approximated mean pre-
and post-operative values. Where the end
point of the measured cytokine could not
be determined, the value at the limit of
detection was used. Aqueous cytokines:
interleukin (IL)-1α, IL-1β, IL-4, IL-6, IL-
8, vascular endothelial growth factor
(VEGF), tumor necrosis factor-α
(TNFα), interferon (IFN)-γ, epidermal
growth factor (EGF), and monocyte
chemotactic protein-1 (MCP-1).
Figure 2. The post to preoperative serum
cytokine ratio was determined using the
approximated mean pre- and post-opera-
tive values.  Where the end point of the
measured cytokine could not be deter-
mined, the value at the limit of detection
was used. Serum cytokines: interleukin
(IL)-1α, IL-1β, IL-4, IL-6, IL-8, vascu-
lar endothelial growth factor (VEGF),
tumor necrosis factor-α (TNFα), inter-
feron (IFN)-γ, epidermal growth factor
(EGF), and monocyte chemotactic pro-
tein-1 (MCP-1).
1134The 18 h postoperative time point was chosen because it
was the most convenient for the patient and also because
cytokine concentrations based on IL-6 have been found to be
high at this time [17]. Clearly, because only two time points
were sampled, little inferences can be made. Nevertheless, of
the 12 cytokines analyzed in this study, all except EGF were
detectable in the aqueous preoperatively and all except IL-2
and IL-10 showed significant increases 18 h following sur-
gery. In all of the study groups, aqueous cytokine levels broadly
showed three different patterns of response at 18 h postopera-
tively: those showing a high increase, IL-8, IL-6, IFN-γ, and
TNF-α; those showing a medium increase, IL-1β, VEGF, IL-
4, and MCP-1; and those showing little or no increase, EGF,
IL-1α, IL-2, and IL-10. Thus, as far as aqueous levels are con-
cerned, predominantly macrophage-derived cytokines (TNF-
α, IL-1β, IL-6, IL-8, and MCP1) and predominantly endothe-
lial cell-derived cytokines (VEGF, TNF-α, IL-6, IL-8, and
MCP) showed several fold increases. This may be reflecting a
breakdown in the blood-aqueous barrier. The results for IL-6
are similar to those of Malacaze et al who reported low to
undetectable preoperative aqueous IL-6 levels with several fold
increases three days following extracapsular cataract surgery
with no detectable IL-6 bioactivity in the serum [14].
General anesthesia using Fentanyl, Thiopentone,
Isoflurane, Propofol, and nitrous oxide has been associated
with an increase in IFN-γ, IFN-α, TNF-α, and soluble
interleukin-2 receptor synthesis, but not in IL-1β and IL-6 [23].
Anesthetic technique can modify the balance of cytokines as-
sociated with surgery [24,25]. Ketamine, an intravenous an-
esthetic agent, had been found to have suppressive effects on
macrophage functions including inflammatory cytokine pro-
duction possibly via reduction of mitochondrial membrane
potential in cell culture [26]. It has also been shown to sup-
press staphylococcal enterotoxin B-induced proinflammatory
cytokine production in human whole blood [27]. In our study,
patients having surgery under GA received a bolus injection
of Propofol or an infusion of 1 mg/Kg of ketamine. We found
no suppressive effect of Propofol on TNF-α levels as has been
reported in studies on rats [28]. Similarly, with regard to
ketamine, the absence of a detectable effect on aqueous or
serum cytokine responses may reflect poor penetration of
ketamine into the eye, peculiarity of eye surgery, or insuffi-
cient therapeutic levels. Although in rats the minimum effec-
tive dose to inhibit IL-6 secretion is between 5-10 mg/Kg
[29,30], the dose used in our study (1 mg/Kg) was higher than
that used by Roytblat et al. (0.25 mg/Kg) who noted an at-
tenuation of postoperative serum IL-6 levels in the patients
given ketamine in a study on patients undergoing cardio-pul-
monary bypass [17]. Although cataract surgery would not be
expected to cause a major systemic insult, serum cytokine lev-
els also showed a slight but significant increase following sur-
gery, reflecting some systemic effect or release into the circu-
lation. We could not detect any differences between general
or local anesthesia in terms of the clinical or cytokine response.
Although increases in IL-1β, IL-6, and IL-8 are attenuated by
high doses of lidocaine in high concentrations (0.5 mg/ml)
[31], this level is unlikely to be reached in the anterior cham-
ber following peribulbar injection.
It has previously been reported that greater
phacoemulsification energy is required for higher grades of
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TABLE 3. PRE AND POSTOPERATIVE SERUM CYTOKINE RESPONSE FOLLOWING CATARACT SURGERY
Patient groups: general anesthesia with (GA+) and without (GA-) ketamine, and local anesthesia (LA). Serum cytokines: interleukin (IL)-1α,
IL-1β, IL-4, IL-6, IL-8, vascular endothelial growth factor (VEGF), tumor necrosis factor-α (TNFα), interferon (IFN)-γ, epidermal growth
factor (EGF), and monocyte chemotactic protein-1 (MCP-1). Although the changes are smaller compared to the aqueous levels (Table 1), note
the comparative changes in the pre and postoperative levels of the measured serum cytokines such as IL-6 and IL-2. There were no differences
between the three patient groups.
1135nuclear color (NC) and nuclear opalescence (NO) as graded
by the Lens Opacities Classification System, version III
(LOCSIII) [32]. Although not a primary outcome measure and
therefore speculative, the absence of a detectable correlation
between aqueous cytokine response and effective
phacoemulsification time/energy suggests that the aqueous
cytokine response at 18 h bears little correlation with the
amount of phacoemulsification energy within the range used.
Although the inflammatory cytokine response may be rela-
tively standard for this type of surgery, it may be more marked
in complicated or difficult surgical cases thus indicates fur-
ther work in such cases.
In the absence of additional time point measurements, it
is difficult to speculate on the significance of the cytokine re-
sponses measured. That is, although our results represent snap-
shots of aqueous cytokine levels pre and 18 h post cataract
surgery, the cytokine response following corneal infection [33]
or trauma [34] is intense and usually short-lived. Whether the
aqueous levels of these cytokines remain elevated postopera-
tively is clearly important for further surgery such as penetrat-
ing keratoplasty following cataract or glaucoma filtration sur-
gery. It would be useful to measure these cytokines as well as
TGF-β at other postoperative time points, particularly later
time points, to determine the response pattern and maintenance
of the response. Although there is between subject variation,
the response (at least at 18 h) appears reasonably uniform so
that different patient groups could be selected for different
time intervals which would mean repeated individual testing
is unnecessary. In addition, it would be informative to mea-
sure the cytokine response in cases where the postoperative
inflammatory response has been greater than expected and to
correlate or standardize with the total aqueous protein con-
centration. In conclusion, we have found that aqueous cytokine
levels showed three different patterns of response at 18 h post-
cataract surgery; those that were highly increased (IL-8, IL-6,
IFN-γ, and TNF-α), intermediately increased (IL-1β, VEGF,
IL-4, and MCP-1), and those with little to no change (EGF,
IL-1α, IL-2, and IL-10). This response appears to be unaf-
fected by the use of ketamine.
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